Sagimet Biosciences Inc.
SGMT
$2.21
$0.199.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.35% | -0.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.65% | 59.62% | |||
| Operating Income | -7.65% | -59.62% | |||
| Income Before Tax | -10.82% | -80.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.82% | -80.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.82% | -80.08% | |||
| EBIT | -7.65% | -59.62% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -10.64% | -78.77% | |||
| Normalized Basic EPS | -10.62% | -78.81% | |||
| EPS Diluted | -10.64% | -78.77% | |||
| Normalized Diluted EPS | -10.62% | -78.81% | |||
| Average Basic Shares Outstanding | 0.16% | 0.72% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||